Results 251 to 260 of about 1,402,288 (364)
Bioactive glass (BAG) S53P4 is a synthetic bone substitute. Clinically it has been used in the treatment of benign bone tumor surgery, in spine surgery, in trauma surgery, in frontal sinus surgery, in diabetic foot osteomyelitis surgery, in mastoid surgery, in oral and maxillofacial surgery in more than 4000 patients, with excellent clinical long‐term ...
Sebastian CE Lindfors +2 more
wiley +1 more source
COVID-19 Infection Changed P300 Latency in Patients With Psychosis: A Retrospective Cohort Study. [PDF]
Jiang X, Qiu S, Wang W, Xu S, Wang S.
europepmc +1 more source
CD207+ dendritic cells (DCs) drive emphysema by promoting CD8⁺ T cell cytotoxicity via Birbeck granule‐dependent MHC‐I antigen presentation. This DC subset is expanded by cigarette smoke‐induced oxidative stress, which triggers granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) release from airway epithelium.
Shurui Xuan +10 more
wiley +1 more source
Endoscopic incisional therapy for esophageal strictures in children: a retrospective cohort study. [PDF]
Rechtman OG, Slae M.
europepmc +1 more source
Kidney Histopathology and Prediction of Kidney Failure: A Retrospective Cohort Study
Michael T. Eadon +14 more
openalex +2 more sources
This study successfully establishes adamantinomatous craniopharyngioma (ACP) patient‐derived organoids (PDOs) that preserve the histopathological and genetic features of the original tumors. Through drug sensitivity assays and subsequent mechanistic analyses, the study demonstrates that Ceritinib exerts its inhibitory effects on ACP PDO growth by ...
Huarong Zhang +15 more
wiley +1 more source
Association Between Pneumoconiosis and Pleural Empyema: A Retrospective Cohort Study. [PDF]
Soh KS, Lin CL, Lee WM, Cho DY.
europepmc +1 more source
Acute Kidney Disease following Acute Kidney Injury in Children—A Retrospective Observational Cohort Study on Risk Factors and Outcomes [PDF]
Flavia Chisavu +8 more
openalex +1 more source
Triple‐negative breast cancer exhibits variable sensitivity to PRMT5 inhibition. Basal interferon signaling is identified as a key biomarker of response. PARP inhibition with olaparib induces IFN signaling, sensitizing resistant TNBC cells to PRMT5 inhibitors.
Ziwen Zhang +9 more
wiley +1 more source

